rs61738625

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_001282225.2(ADA2):ā€‹c.1467G>Cā€‹(p.Glu489Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000917 in 1,612,710 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00051 ( 0 hom., cov: 33)
Exomes š‘“: 0.00096 ( 1 hom. )

Consequence

ADA2
NM_001282225.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 0.394
Variant links:
Genes affected
ADA2 (HGNC:1839): (adenosine deaminase 2) This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10696912).
BP6
Variant 22-17181552-C-G is Benign according to our data. Variant chr22-17181552-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 569098.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADA2NM_001282225.2 linkuse as main transcriptc.1467G>C p.Glu489Asp missense_variant 10/10 ENST00000399837.8 NP_001269154.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADA2ENST00000399837.8 linkuse as main transcriptc.1467G>C p.Glu489Asp missense_variant 10/101 NM_001282225.2 ENSP00000382731 P1Q9NZK5-1

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152202
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000955
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000398
AC:
100
AN:
251338
Hom.:
0
AF XY:
0.000397
AC XY:
54
AN XY:
135850
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000774
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000960
AC:
1402
AN:
1460508
Hom.:
1
Cov.:
29
AF XY:
0.000921
AC XY:
669
AN XY:
726644
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00122
Gnomad4 OTH exome
AF:
0.000530
GnomAD4 genome
AF:
0.000506
AC:
77
AN:
152202
Hom.:
0
Cov.:
33
AF XY:
0.000309
AC XY:
23
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000955
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000650
Hom.:
0
Bravo
AF:
0.000487
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000247
AC:
30
EpiCase
AF:
0.000763
EpiControl
AF:
0.000889

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoJul 11, 2022DNA sequence analysis of the ADA2 gene demonstrated a sequence change, c.1467G>C, in exon 10 that results in an amino acid change, p.Glu489Asp. This sequence change does not appear to have been previously described in individuals with ADA2-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.075% in the European subpopulation (dbSNP rs61738625). The p.Glu489Asp change affects a poorly conserved amino acid residue located in a domain of the ADA2 protein that is known to be functional. The p.Glu489Asp substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Glu489Asp change remains unknown at this time. -
Vasculitis due to ADA2 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 28, 2023This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 489 of the ADA2 protein (p.Glu489Asp). This variant is present in population databases (rs61738625, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with ADA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 569098). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Autoinflammatory syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJan 22, 2021- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2023ADA2: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
2.9
DANN
Benign
0.94
DEOGEN2
Benign
0.047
T;T;T;.;T;T;.;.
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.072
N
LIST_S2
Benign
0.39
T;.;.;T;.;T;.;T
M_CAP
Benign
0.079
D
MetaRNN
Benign
0.11
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.65
T
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-2.3
.;N;N;N;N;.;N;.
REVEL
Benign
0.15
Sift
Benign
0.14
.;T;T;T;T;.;T;.
Sift4G
Benign
0.085
T;T;T;D;T;.;T;.
Polyphen
0.0020, 0.024
.;B;B;B;B;B;.;.
Vest4
0.036
MutPred
0.60
.;Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);.;Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);.;.;
MVP
0.62
MPC
0.049
ClinPred
0.015
T
GERP RS
1.3
Varity_R
0.19
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61738625; hg19: chr22-17662442; API